Avaliação do custo do tratamento de úlceras por pressão em pacientes hospitalizados usando curativos industrializados Evaluation of the cost of treating pressure ulcers in hospitalized patients using industrialized dressings

Este trabalho avaliou o uso de curativos industrializados: poliuretano, hidrogel, carvão ativo e também hidrogel com alginato, no tratamento de úlcera por pressão na Clínica Neurocirúrgica do Hospital da Restauração. O objetivo foi identificar o fator crítico que aumenta a demanda e custos com curativos industrializados. A avaliação, realizada na Clínica Neurocirúrgica, identificou os indivíduos que apresentaram risco de desenvolver úlcera por pressão. 62 pacientes foram avaliados e a prevalência foi de 22,6%, segundo escore obtido na escala de Braden. A avaliação comparativa entre indivíduos que receberam medidas preventivas e entre os que não receberam mostrou que o custo médio diário de hospitalização para o primeiro grupo foi 45% maior que para o segundo grupo. O teste de Wilcoxon-Mann-Withiney comparou a população de risco com a população de baixo risco, mostrando que a análise dos escores da Escala de Braden entre os grupos apresenta diferenças estatisticamente significativas quando estas duas populações são comparadas, intervalo de confiança de 95%. Úlcera por pressão é um indicador de qualidade dos serviços de saúde. Pode-se reduzir custo e oferecer serviços públicos de maior qualidade se forem implantados treinamentos com a equipe de enfermagem, usando um protocolo de medidas preventivas baseado em um teste de avaliação de risco como a escala de Braden.<br>This work evaluated wound dresses used in the Neurosurgery Department of Restauração Hospital: polyurethane, hydrogel and activated carbon wound dresses and hydrogel with alginate used for pressure ulcer care. This work aimed to identify a critical factor that increases demand and cost of wound dresses. The evaluation conducted at the Neurosurgery Department identified individuals at risk of pressure ulcer development. Sixty-two patients were evaluated and the prevalence of pressure ulcer was 22.6% according to the Braden scale. Comparative evaluation between patients that didn't receive preventive measures and others that received, showed that the average daily cost of hospitalization for the first group was 45% higher than the mean for the second group. The Wilcoxon-Mann-Withiney test compared the population at risk to develop pressure ulcer and population at low risk showing that the evaluation of Braden Scale scores between the groups presents statistically significant differences and confidence limits of 95%. Pressure ulcer is a key quality indicator in health services.It is possible to reduce costs and offer higher quality public health services by implementing a training program of nursing staff using a preventive measure protocol based on a test to evaluate risk as Braden Scale

CKD: The burden of disease invisible to research funders

The uptake of the current concept of chronic kidney disease (CKD) by the public, physicians and health authorities is low. Physicians still mix up CKD with chronic kidney insufficiency or failure. In a recent manuscript, only 23% of participants in a cohort of persons with CKD had been diagnosed by their physicians as having CKD while 29% has a diagnosis of cancer and 82% had a diagnosis of hypertension. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. A prevalent view is that for those in whom kidneys fail, the problem is solved by dialysis or kidney transplantation. However, the main burden of CKD is accelerated aging and all-cause and cardiovascular premature death. CKD is the most prevalent risk factor for lethal COVID-19 and the factor that most increases the risk of death in COVID-19, after old age. Moreover, men and women undergoing KRT still have an annual mortality which is 10-100-fold higher than similar age peers, and life expectancy is shortened by around 40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth global cause of death by 2040 and the second cause of death in Spain before the end of the century, a time when 1 in 4 Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded CIBER network research structure in Spain. Leading Spanish kidney researchers grouped in the kidney collaborative research network REDINREN have now applied for the RICORS call of collaborative research in Spain with the support of the Spanish Society of Nephrology, ALCER and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true. However, only the highest level of research funding through the CIBER will allow to adequately address the issue before it is too late. (C) 2021 Sociedad Espanola de Nefrologia. Published by Elsevier Espana, S.L.U